| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | President and CEO, Director, 10%+ Owner | Stock Option (right to buy) | 519,000 | 13 Feb 2025 | Direct | ||
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | President and CEO, Director, 10%+ Owner | Stock Option (right to buy) | 181,500 | 13 Feb 2025 | By Spouse |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 13 Feb 2025 | 2 | $0 | 4 | President and CEO, Director, 10%+ Owner | 18 Feb 2025, 16:30 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 15 Sep 2024 | 2 | $0 | 4 | President and CEO, Director, 10%+ Owner | 17 Sep 2024, 17:01 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 25 Apr 2023 | 2 | $0 | 4 | President and CEO, Director, 10%+ Owner | 27 Apr 2023, 16:31 |